MIST
MIST
NASDAQ · Pharmaceuticals

Milestone Pharmaceuticals In

$1.92
+0.03 (+1.59%)
As of May 10, 10:37 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 2 17%
Sell 0 0%
Price Target
Analyst Price Target +2,266.1% upside
Low Target $30.70
Average Target $45.43
High Target $53.70
Current Price $1.92
Current
$1.92
Target
$45.43
$30.70 $45.43 avg $53.70
Scenario Analysis
Bear Case
$30.70
1,499.0%
Low target
Base Case
$45.43
+2,266.1%
Avg target
Bull Case
$53.70
+2,696.9%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$3.06
-37.3% from high
52-Week Low
$1.00
+92.0% from low
Target vs 52W High
$45.43
+1,384.6% vs high
Next Earnings Report
May 13, 2026 · Before Market Open
1d
tomorrow
EPS Est: $0.31
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%